| 000 | 01698 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250511214615.0 | ||
| 264 | 0 | _c19901012 | |
| 008 | 199010s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/0140-6736(90)92158-e _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGriffith, M J | |
| 245 | 0 | 0 |
_aRelative efficacy and safety of intravenous drugs for termination of sustained ventricular tachycardia. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cSep 1990 |
||
| 300 |
_a670-3 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAdenosine _xadministration & dosage |
| 650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCardiac Pacing, Artificial |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDisopyramide _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aElectric Countershock |
| 650 | 0 | 4 | _aElectrocardiography |
| 650 | 0 | 4 |
_aFlecainide _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypotension _xchemically induced |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aLidocaine _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aSotalol _xadministration & dosage |
| 650 | 0 | 4 |
_aTachycardia _xdrug therapy |
| 700 | 1 | _aLinker, N J | |
| 700 | 1 | _aGarratt, C J | |
| 700 | 1 | _aWard, D E | |
| 700 | 1 | _aCamm, A J | |
| 773 | 0 |
_tLancet (London, England) _gvol. 336 _gno. 8716 _gp. 670-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0140-6736(90)92158-e _zAvailable from publisher's website |
| 999 |
_c1982047 _d1982047 |
||